The data suggest that the subset of FXN epialleles with <70% methylation underlies the potential for FXN reactivation via HDACi-109 treatment in FRDA, and such alleles constitute a substantial subset of somatic FXN genes in FRDA patients. The gene discussed is FXN; the disease is Friedreich ataxia.